Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Healthy living strategies to help recover from pulmonary embolism

Official title: Recovery After Acute Pulmonary Embolism

Run by University of Rochester · NCT06784492 · Data updated 2026-11-12

This study tests if two healthy living strategies can help people recover better after being hospitalized for a pulmonary embolism.

More Pulmonary Embolism trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Rochester
Academic / other
Locations1 site (Rochester, New York)
StatusRecruiting
StartedFebruary 27, 2025
Main results expectedOctober 1, 2027
Study endsDecember 1, 2027
Registry record updatedApril 8, 2026
Trial IDNCT06784492 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include English-speaking adults over 18 who have been hospitalized for acute pulmonary embolism and meet specific cardiac criteria.

Probably not a fit

Patients who are pregnant, have severe cardiac issues, or are unable to walk may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of two different healthy living strategies in aiding recovery for patients who have been hospitalized due to acute pulmonary embolism. Participants will undergo an 8-week program that includes these interventions alongside standard anticoagulation treatment. The primary outcome will be measured by assessing changes in cardiac effort during a six-minute walk test. The study seeks to determine if these lifestyle changes can enhance recovery outcomes for affected individuals.

Why it matters

Potential benefit: If successful, this study could improve recovery rates and overall health outcomes for patients recovering from acute pulmonary embolism.

How similar studies have gone: While similar approaches have been explored, this specific combination of healthy living strategies in the context of acute pulmonary embolism recovery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. English speaking (\>18 years old). Daily messages will be sent in English.
2. Acute PE with at least one of the following:

   1. any right ventricular enlargement or dysfunction on echocardiogram;
   2. CT Angiogram reporting any right ventricular enlargement; or
   3. elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
3. Rate controlled atrial arrythmias (resting heart rate \<110 beats/m) are eligible for enrollment. This includes atrial fibrillations. This is standard of care management for atrial fibrillation.
4. Subjects do need to take prescribed anticoagulation.

Exclusion Criteria:

1. Pregnancy.
2. Cardiac Effort \>3.5 beats/m during 6MWT.
3. Resting tachycardia \>110 beats/m at hospital discharge.
4. Chronic Thromboembolic Pulmonary Hypertension
5. Systolic blood pressure \>180 mmHg at hospital discharge.
6. Inability to walk.
7. Estimated prognosis \<12 months at the time of discharge due to underlying co-morbidities (e.g., cancer).
8. Advanced neurologic disease and would not be able to comply with the messages.
9. Lack of access to email or text messaging 10. Inability or unwillingness to follow daily instructions.

Where it's running

  • University of Rochester Medical Center
    Rochester, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.